FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

19307611000001100: Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jul 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2582651000001110 Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2582661000001113 Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Is a Ropinirole 2mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has AMP Ralnea XL 2mg tablets (Krka UK Ltd) true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Ropinirole hydrochloride true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ralnea XL 2mg tablets (Krka UK Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start